Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

NCT03850782 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03850782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03850782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2019
Completion date
August 8, 2025
Enrollment
515 (actual)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open-angle glaucoma